PTC Therapeutics (PTCT) stock on watch as company receives FDA approval for gene therapy Kebilidi for AADC deficiency. Read ...

Multibagger Stock: PTC Industries, an engineering component manufacturer, has experienced a remarkable surge in its share ...

PTC Therapeutics (PTCT) announced that the FDA accelerated approval of its gene therapy for the treatment of AADC deficiency, the first-ever ...

Nov 13 (Reuters) - The U.S. Food and Drug Administration approved PTC Therapeutics' (PTCT.O), opens new tab gene therapy to ...

We don't have anything new to report at this time," AstraZeneca's Chief Financial Officer Aradhana Sarin said during a media ...

The letter from the central bank to Krishi Bank stated that approval from the appropriate government authority – the Power ...

In a report released on November 8, Gena Wang from Barclays maintained a Hold rating on PTC Therapeutics (PTCT – Research Report), with a ...

Q3 2024 Earnings Call Transcript November 7, 2024 PTC Therapeutics, Inc. beats earnings expectations. Reported EPS is $-1.39, ...

The move comes after Adani Power threatened to stop the power supply to Bangladesh by cutting its supply to half and asking for unpaid dues worth $843 million ...

Integration of CLM and PLM enables a streamlined approach to configuration management, leading to faster time to market and more satisfied customers COPENHAGEN, Denmark, Nov. 1, 2024 /PRNewswire/ ...

Analysts expect PTC to post earnings of $1.43 per share for the quarter. Individual interested in participating in the company’s earnings conference call can do so using this link. PTC (NASDAQ ...